The HTA was asked to provide information on the quality indicators for ovarian tissue preservation and transplantation for the purpose of fertility preservation, for patients who are undergoing cancer treatment. HTA was also questioned on the ongoing quality checks of post-cryopreservation tissues.
Request date
Audience
Exclude from search
No